You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 1, July 6, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Patient Preference and Validity of Randomized Controlled Trials

Since this article does not have an abstract, we have provided the first 140 words of the full text and any section headings.

To the Editor: Dr King and colleagues1 concluded that there is little evidence that preferences affect trial validity. However, as these were observational comparisons, any preference effects in these trials may have been confounded by characteristics associated with preference. We believe that a better approach to observing the role of patient preferences on study outcomes is to accept that a significant proportion of patients who consent to randomization will have a treatment preference, particularly for the novel therapy.2-3 We ask patients’ preferences before randomization and then randomize all consenting patients irrespective of their baseline preferences. In this way we can examine within the safety of a completely randomized design whether there is an interaction between baseline preference and outcome. We recommend that preferences be measured at baseline before random allocation in all studies where preference may affect the outcome.

David Torgerson, MSc, PhD
djt6@york.ac.uk
Department of Health Sciences
University of York
York, England

Jennifer Klaber Moffett, MSCP, PhD
Institute of Rehabilitation
University of Hull
Hull, England

1. King M, Nazareth I, Lampe F, et al. Impact of participant and physician intervention preferences on randomized trials: a systematic review. JAMA. 2005;293:1089-1099. FREE FULL TEXT
2. Torgerson DJ, Klaber Moffett J, Russell IT. Including patient preferences in randomised clinical trials. J Health Serv Res Policy. 1996;1:194-197. PUBMED
3. Klaber Moffett JA, Jackson DA, Richmond S, et al. Randomised trial of brief physiotherapy intervention compared with usual physiotherapy for neck pain patients: outcomes and patients preferences. BMJ. 2005;330:75. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;294:41-42.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Patient Preference and Validity of Randomized Controlled Trials
Alex H. Cho, George L. Jackson, and Hayden B. Bosworth
JAMA. 2005;294(1):41.
EXTRACT | FULL TEXT  

Patient Preference and Validity of Randomized Controlled Trials—Reply
Michael King, Irwin Nazareth, Fiona Lampe, and Peter Bower
JAMA. 2005;294(1):42.
EXTRACT | FULL TEXT  

Impact of Participant and Physician Intervention Preferences on Randomized Trials: A Systematic Review
Michael King, Irwin Nazareth, Fiona Lampe, Peter Bower, Martin Chandler, Maria Morou, Bonnie Sibbald, and Rosalind Lai
JAMA. 2005;293(9):1089-1099.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.